Patents by Inventor Jenny J. Kim

Jenny J. Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Screening method for identifying anti-PACAP antibodies or antibody fragments suitable for use in treating or preventing PACAP-associated photophobia or light aversion
    Patent number: 11993648
    Abstract: This invention relates to methods of screening for anti-PACAP antibodies, or anti-PACAP receptor antibodies, and antigen binding fragments thereof, for potential use in treating or preventing PACAP-associated photophobia or light aversion, and therapeutic compositions containing and methods of using anti-PACAP antibodies, or anti-PACAP receptor antibodies, and antigen binding fragments thereof.
    Type: Grant
    Filed: November 20, 2020
    Date of Patent: May 28, 2024
    Assignees: H. LUNDBECK A/S
    Inventors: Adisa Kuburas, Bianca Mason, Levi P. Sowers, Andrew F. Russo, Maria-Cristina Loomis, Leon F. Garcia-Martinez, Benjamin H. Dutzar, Daniel S. Allison, Katherine Lee Hendrix, Ethan W. Ojala, Pei Fan, Jeffrey T. L. Smith, John A. Latham, Charlie Karasek, Jenny Mulligan, Michelle Scalley-Kim, Erica Stewart, Vanessa Lisbeth Rubin, Jens J. Billgren
  • Treatment of headache, migraine and/or photophobia conditions using humanized anti-PACAP antibodies
    Patent number: 11938185
    Abstract: The present invention is directed to antibodies and antigen binding fragments thereof having binding specificity for PACAP. The antibodies and antigen binding fragments thereof comprise the sequences of the VH, VL, and CDR polypeptides described herein, and the polynucleotides encoding them. Antibodies and antigen binding fragments described herein bind to and/or compete for binding to the same linear or conformational epitope(s) on human PACAP as an anti-PACAP antibody. The invention contemplates conjugates of anti-PACAP antibodies and binding fragments thereof conjugated to one or more functional or detectable moieties. Methods of making said anti-PACAP antibodies and antigen binding fragments thereof are also contemplated.
    Type: Grant
    Filed: December 15, 2020
    Date of Patent: March 26, 2024
    Assignee: H. LUNDBECK A/S
    Inventors: Maria-Cristina Loomis, Leon F. Garcia-Martinez, Benjamin H. Dutzar, Daniel S. Allison, Katherine Lee Hendrix, Ethan W. Ojala, Pei Fan, Jeffrey T. L. Smith, John A. Latham, Charlie Karasek, Jenny Mulligan, Michelle Scalley-Kim, Erica Stewart, Vanessa Lisbeth Rubin, Jens J. Billgren
  • COMPOSITIONS AND METHODS FOR TREATING SKIN AND MUCOUS MEMBRANE DISEASES
    Publication number: 20210128641
    Abstract: This invention relates to topical probiotic formulations for treating skin conditions.
    Type: Application
    Filed: June 15, 2020
    Publication date: May 6, 2021
    Inventors: Jenny J. Kim, Jackson T. Champer, Yang Yu
  • Treatment of Inflammatory and Infectious Skin Disorders
    Publication number: 20170087116
    Abstract: Disclosed herein is a composition comprising of resveratrol and/or derivatives thereof and/or functionally related compounds and benzoyl peroxide and/or derivatives thereof and/or functionally related compounds for the treatment of acne and other inflammatory or infectious skin disorders. Also disclosed are methods of treating acne and other inflammatory and infectious skin disorders using the compositions described herein.
    Type: Application
    Filed: December 7, 2016
    Publication date: March 30, 2017
    Inventors: Emma Taylor, Jackson Champer, Jenny J. Kim
  • COMPOSITIONS AND METHODS FOR TREATING SKIN AND MUCOUS MEMBRANE DISEASES
    Publication number: 20170065647
    Abstract: This invention relates to topical probiotic formulations for treating skin conditions.
    Type: Application
    Filed: May 7, 2015
    Publication date: March 9, 2017
    Inventors: Jenny J. Kim, Jackson T. Champer, Yang Yu
  • Treatment of inflammatory and infectious skin disorders
    Patent number: 9549905
    Abstract: Disclosed herein is a composition comprising of resveratrol and/or derivatives thereof and/or functionally related compounds and benzoyl peroxide and/or derivatives thereof and/or functionally related compounds for the treatment of acne and other inflammatory or infectious skin disorders. Also disclosed are methods of treating acne and other inflammatory and infectious skin disorders using the compositions described herein.
    Type: Grant
    Filed: March 23, 2012
    Date of Patent: January 24, 2017
    Assignee: The Regents of the University of California
    Inventors: Emma Taylor, Jackson Thomas S. Champer, Jenny J. Kim
  • TREATMENT OF INFLAMMATORY AND INFECTIOUS SKIN DISORDERS
    Publication number: 20140018437
    Abstract: Disclosed herein is a composition comprising of resveratrol and/or derivatives thereof and/or functionally related compounds and benzoyl peroxide and/or derivatives thereof and/or functionally related compounds for the treatment of acne and other inflammatory or infectious skin disorders. Also disclosed are methods of treating acne and other inflammatory and infectious skin disorders using the compositions described herein.
    Type: Application
    Filed: March 23, 2012
    Publication date: January 16, 2014
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Emma Taylor, Jackson Thomas S. Champer, Jenny J. Kim
  • Granulysin peptides and methods of use thereof
    Patent number: 8357365
    Abstract: Granulysin peptides are small antimicrobial agents with potent activity. A pharmaceutical composition comprising granulysin peptides as an active agent is administered therapeutically to a patient for exfoliation, e.g. for the treatment of skin lesions.
    Type: Grant
    Filed: February 14, 2006
    Date of Patent: January 22, 2013
    Assignee: The Regents of the University of California
    Inventor: Jenny J. Kim
  • GRANULYSIN PEPTIDES AND METHODS OF USE THEREOF
    Publication number: 20090117093
    Abstract: Granulysin peptides are small antimicrobial agents with potent activity. A pharmaceutical composition comprising granulysin peptides as an active agent is administered therapeutically to a patient for exfoliation, e.g. for the treatment of skin lesions.
    Type: Application
    Filed: February 14, 2006
    Publication date: May 7, 2009
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventor: Jenny J. Kim
  • Granulysin peptides and methods of use thereof
    Patent number: 7459439
    Abstract: Granulysin peptides are small antimicrobial agents with potent activity against bacteria and inflammation. A pharmaceutical composition comprising granulysin peptides as an active agent is administered therapeutically to a patient suffering from a microbial infection.
    Type: Grant
    Filed: December 14, 2005
    Date of Patent: December 2, 2008
    Assignee: The Regents of the University of California
    Inventors: Robert L. Modlin, Jenny J. Kim, Daniel H. Anderson, David S. Eisenberg, Richard L. Gallo